Slika omota

Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Human onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is controlled almost exclusively by the drug ivermectin, which prevents pathology by targeting the microfilariae. However, this reliance on a single control tool has led to interest in vaccination as a potentially complementa...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Benjamin L Makepeace (Autor), Siv Aina Jensen (Autor), Sandra J Laney (Autor), Charles K Nfon (Autor), Leo M Njongmeta (Autor), Vincent N Tanya (Autor), Steven A Williams (Autor), Albert E Bianco (Autor), Alexander J Trees (Autor)
Format:	Knjiga
Izdano:	Public Library of Science (PLoS), 2009-01-01T00:00:00Z.
Teme:	article
Online pristup:	Connect to this object online.
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Resolution of Eczema with Multivalent Peptides
od: Laura L. Eggink, i dr.
Izdano: (2022)

The Onchocerciasis Vaccine for Africa--TOVA--Initiative.
od: Peter J Hotez, i dr.
Izdano: (2015)

Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
od: José Antonio Lebrón, i dr.
Izdano: (2021)

AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design
od: Mario Sanches, i dr.
Izdano: (2020)

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
od: Pedro Cecílio, i dr.
Izdano: (2017)

Revisiting Oral Fluoroquinolone and Multivalent Cation Drug-Drug Interactions: Are They Still Relevant?
od: Stuart K. Pitman, i dr.
Izdano: (2019)

Click-Free Synthesis of a Multivalent Tricyclic Peptide as a Molecular Transporter
od: Sumit Kumar, i dr.
Izdano: (2020)

Getting it right-the Australian Childhood Immunisation Register and immunisation rates in south‐eastern Sydney
od: Susan J. Botham, i dr.
Izdano: (2004)

Human onchocerciasis in Brazil: an overview
od: Anthony J. Shelley

Human onchocerciasis in Brazil: an overview
od: Anthony J. Shelley

Human onchocerciasis in Brazil: an overview
od: Shelley Anthony J.
Izdano: (2002)

In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes
od: Diana A. Sousa, i dr.
Izdano: (2022)

The future of onchocerciasis control in Africa.
od: Catherine Hodgkin, i dr.
Izdano: (2007)

Investigating protein-excipient interactions of a multivalent VHH therapeutic protein using NMR spectroscopy
od: Jainik Panchal, i dr.
Izdano: (2022)

Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells
od: Valeria Unida, i dr.
Izdano: (2022)

Views of Zulus and Southern Sothos on immunisation
od: A.J. Lubbe
Izdano: (1984)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
od: Carabin Hélène, i dr.
Izdano: (2003)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC).
od: Donald A P Bundy, i dr.
Izdano: (2015)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
od: Nana O Wilson, i dr.
Izdano: (2016)

Immunisation Status Of Pregnant Women In Bihar
od: Yadav R. J, i dr.
Izdano: (1998)

Children overdue for immunisation: a question of coverage or reporting? An audit of the Australian Immunisation Register
od: Charlee Law, i dr.
Izdano: (2019)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
od: Achille S Nikièma, i dr.
Izdano: (2021)

Immunisation coverage in Australia corrected for under‐reporting to the Australian Childhood Immunisation Register
od: Brynley P. Hull, i dr.
Izdano: (2003)

Coefficients bounds on a certain class of multivalent analytic functions / Laxmipriya Parida and Ashok Kumar Sahoo
od: Parida, Laxmipriya, i dr.
Izdano: (2022)

Dual-Targeted Self-Assembled DNA Hydrogels Decorated With Multivalent Aptamers Loaded With DOX for Anticancer Therapy
od: Fangfang Jin, i dr.
Izdano: (2022)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
od: Peter J. Halfmann, i dr.
Izdano: (2021)

Simuliidae and the transmission and control of human Onchocerciasis in Latin America
od: A. J. Shelley
Izdano: (1991)

The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
od: Moses N Katabarwa, i dr.
Izdano: (2020)

The onchocerciasis hypothesis of nodding syndrome.
od: Robert Colebunders, i dr.
Izdano: (2023)

Onchocerciasis-associated epilepsy and biomarkers.
od: Robert Colebunders, i dr.
Izdano: (2024)

Onchocerciasis-associated epilepsy and biomarkers
od: Robert Colebunders, i dr.
Izdano: (2024)

Elimination of Onchocerciasis from Mexico.
od: Mario A Rodríguez-Pérez, i dr.
Izdano: (2015)

Inequalities in COVID-19 disruption of routine immunisations and returning to pre-COVID immunisation rates
od: Subhash Chandir, i dr.
Izdano: (2021)

Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis.
od: Judith R Denery, i dr.
Izdano: (2010)

Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
od: Inga Petersen, i dr.
Izdano: (2023)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
od: Rita Sala, i dr.
Izdano: (2022)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions.
od: Marco A Biamonte, i dr.
Izdano: (2022)

Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal.
od: Yakou Dieye, i dr.
Izdano: (2017)

Strengthening immunisation supply chain systems through the GAVI Alliance Immunisation Supply Chain Strategy
od: Kaleb Brownlow, i dr.
Izdano: (2014)

Australia's contribution to global immunisation
od: Tilman A. Ruff, i dr.
Izdano: (2012)